Specifications
| Item Number | 224909 |
|---|
| For Use With | Dogs |
|---|
| Generic Name | sarolander， moxidectin， and pyrantel |
|---|
| Administration Form | Oral |
|---|
| Common Brand Name(s) | Simparica Trio |
|---|
| Usage | Prevention， Treatment |
|---|
| Kills or Treats | Fleas， Ticks， Roundworms， Hookworms |
|---|
| Repels or Prevents | Heartworms， Fleas |
|---|
| Lifestage | Puppy， Adult |
|---|
| Breed Size | Large Breeds， Giant Breeds |
|---|
| Product Form | Chewable Tablet |
|---|
| Strength | 72 mg Sarolaner， 1.44 mg Moxidectin， 300 mg Pyrantel |
|---|
| Health Condition | Heartworms， Ticks， Fleas， Roundworms， Hookworms |
|---|
| Drug Type | Parasiticide |
|---|
Uses
Monthly Simparica Trio prevents heartworm disease， kills adult fleas and is indicated for the treatment and prevention of flea infestations， the treatment and control of tick infestations， and the treatment and control of roundworm and adult hookworm infections in dogs and puppies 8 weeks of age and older， and weighing 2.8 pounds or greater.
Possible Side Effects
The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.
Drug & Food Interactions
There are no known contraindications for the use of SIMPARICA TRIO.
Precautions
Not for use in humans. Keep this and all drugs out of reach of children. Use with caution in dogs with a history of seizures. Simparica Trio contains sarolaner， a member of the isoxazoline class， which has been associated with neurologic adverse reactions including tremors， ataxia， and seizures in dogs with or without a history of neurologic disorders. The safe use of Simparica Trio has not been evaluated in breeding， pregnant， or lactating dogs. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea.
Comment